Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Options -- Ignore unavailable to you. Want to Upgrade?

To: Seldom_Blue who wrote (5005)	3/14/2000 9:33:00 PM
From: steve mamus	Respond to of 8096

The game in biotechs is a mine field. Even if you can get it thru the FDA you will have the constant destruction of profit margins for all pharmaceuticals due to the government, insurance companies, politicians, public interest groups. This is worse then the oil companies trying to raise oil prices. It is becoming an increasingly no win proposition in many ways. DoK

To: Seldom_Blue who wrote (5005)	3/14/2000 11:57:00 PM
From: cthruu	Read Replies (1) \| Respond to of 8096

That is psychology. I had lost money in NSOL during its last drop from 300, so I was afraid and did not buy it back at 60 this time - missed the entire run to over 500 because I was afraid. Same with RMBS and DELL. I have played entire runs up in YHOO, QCOM, CMGI, etc.as well. Unfortunately I did not ride them down and gave up some profits by holding on too long. Such mistake make better traders out of us. Even though Biotechs are volatile, those are the stocks where a nimble player can make lots of profits. I gave up some in AFFX today but I have no regrets: I have been in IMNX since around 30 - that was 120 two splits ago. I have no reservations about riding Biotechs down. Remember: The thread is about options - not only calls :-) So we trade calls and puts. AFFX confirmed one of my beliefs that selling puts is dangerous. Worse yet, not buying them back for a HUGE profit is more dangerous. Regards: GP